Detalhe da pesquisa
1.
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis.
J Cardiovasc Pharmacol
; 81(1): 70-75, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219195
2.
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry.
Eur J Clin Invest
; 52(12): e13863, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36039486
3.
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry.
J Cardiovasc Pharmacol
; 79(4): 523-529, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983910
4.
Coronary sinus atrial septal defect in a 65-year-old woman: Diagnosis by two- and three-dimensional echocardiography.
Rev Port Cardiol
; 36(1): 67-68, 2017 01.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-27979322